Showing results (31-40 of 110) with videos related to
Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|March 11, 2023
Discovery and anti-tumor activity of 4-(benzylamino)-6-(3,5-dimethylisoxazol-4-yl)quinolin-2(1H)-one (CG13250), a potent, selective and orally bioavailable BET bromodomain inhibitorJay Chauhan, Makoto Yoshioka, Sarah Pogash, et al.Journal of Fluorescence|May 22, 2009
A photostable, pH-invariant fluorescein derivative for single-molecule microscopyBaoxu Liu, Steven Fletcher, Miriam Avadisian, et al.Journal of Medicinal Chemistry|October 29, 2019
Enhancing the Cell Permeability of Stapled Peptides with a Cyclic Cell-Penetrating PeptidePatrick G Dougherty, Jin Wen, Xiaoyan Pan, et al.Oncology Letters|June 1, 2018
Therapeutic potential of Bcl-xL/Mcl-1 synthetic inhibitor JY-1-106 and retinoids for human triple-negative breast cancer treatmentMariarita Perri, Jeremy L Yap, Steven Fletcher, et al.Organic & Biomolecular Chemistry|January 5, 2006
A dialkynoyl analogue of DOPE improves gene transfer of lower-charged, cationic lipoplexesSteven Fletcher, Ayesha Ahmad, Eric Perouzel, et al.Oncotarget|June 4, 2015
Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletionHuabo Wang, Lokendra Sharma, Jie Lu, et al.Chembiochem : a European Journal of Chemical Biology|January 11, 2008
Biophysical properties of CDAN/DOPE-analogue lipoplexes account for enhanced gene deliverySteven Fletcher, Ayesha Ahmad, Wayne S Price, et al.Biochemical Pharmacology|January 14, 2010
A novel small-molecule disrupts Stat3 SH2 domain-phosphotyrosine interactions and Stat3-dependent tumor processesXiaolei Zhang, Peibin Yue, Steven Fletcher, et al.Investigational New Drugs|April 28, 2026
Prostate cancer cells' growth is decreased by novel MYC inhibitorsBita Nickkholgh, Joseph McGrath, Sivanandane Sittadjody, et al.Acta Crystallographica. Section E, Structure Reports Online|June 25, 2013
Ethyl 2,5-di-tert-butyl-5-eth-oxy-4-oxo-4,5-di-hydro-1H-pyrrole-3-carboxyl-ateGerald M Rosen, Sukumaran Muralidharan, Peter Y Zavalij, et al.Pageof 11